GB0325603D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0325603D0
GB0325603D0 GBGB0325603.9A GB0325603A GB0325603D0 GB 0325603 D0 GB0325603 D0 GB 0325603D0 GB 0325603 A GB0325603 A GB 0325603A GB 0325603 D0 GB0325603 D0 GB 0325603D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0325603.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz GmbH
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz GmbH, Sandoz AG filed Critical Sandoz GmbH
Priority to GBGB0325603.9A priority Critical patent/GB0325603D0/en
Publication of GB0325603D0 publication Critical patent/GB0325603D0/en
Priority to AU2004290511A priority patent/AU2004290511A1/en
Priority to JP2006537245A priority patent/JP2007527414A/en
Priority to BRPI0416109-2A priority patent/BRPI0416109A/en
Priority to CN200480032288A priority patent/CN101848705A/en
Priority to EP04797570A priority patent/EP1682096A1/en
Priority to CA002540965A priority patent/CA2540965A1/en
Priority to PCT/EP2004/012437 priority patent/WO2005048992A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0325603.9A 2003-11-03 2003-11-03 Organic compounds Ceased GB0325603D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0325603.9A GB0325603D0 (en) 2003-11-03 2003-11-03 Organic compounds
AU2004290511A AU2004290511A1 (en) 2003-11-03 2004-11-03 Process for preparing clopidogrel compositions
JP2006537245A JP2007527414A (en) 2003-11-03 2004-11-03 Method for producing clopidogrel composition
BRPI0416109-2A BRPI0416109A (en) 2003-11-03 2004-11-03 process for preparing clopidogrel compositions
CN200480032288A CN101848705A (en) 2003-11-03 2004-11-03 Process for preparing clopidogrel compositions
EP04797570A EP1682096A1 (en) 2003-11-03 2004-11-03 Process for preparing clopidogrel compositions
CA002540965A CA2540965A1 (en) 2003-11-03 2004-11-03 Process for preparing clopidogrel compositions
PCT/EP2004/012437 WO2005048992A1 (en) 2003-11-03 2004-11-03 Process for preparing clopidogrel compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0325603.9A GB0325603D0 (en) 2003-11-03 2003-11-03 Organic compounds

Publications (1)

Publication Number Publication Date
GB0325603D0 true GB0325603D0 (en) 2003-12-10

Family

ID=29725839

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0325603.9A Ceased GB0325603D0 (en) 2003-11-03 2003-11-03 Organic compounds

Country Status (8)

Country Link
EP (1) EP1682096A1 (en)
JP (1) JP2007527414A (en)
CN (1) CN101848705A (en)
AU (1) AU2004290511A1 (en)
BR (1) BRPI0416109A (en)
CA (1) CA2540965A1 (en)
GB (1) GB0325603D0 (en)
WO (1) WO2005048992A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
ZA200608569B (en) * 2004-04-20 2007-12-27 Sanofi Aventis Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
ZA200608035B (en) 2004-04-20 2008-07-30 Sanofi Aventis Clopidogrel salt and polymorphic forms thereof
EP1851231A2 (en) * 2005-02-24 2007-11-07 Teva Pharmaceutical Industries Ltd Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
DE202005013839U1 (en) * 2005-09-01 2005-10-27 Helm Ag Tablet containing monobasic acid salt of clopidogrel, useful for preventing thromboembolic events, e.g. stroke or myocardial infarction, contains no ionic or basic auxiliaries or polyethylene glycol
WO2007054968A2 (en) * 2005-09-20 2007-05-18 Torrent Pahrmaceuticals Limited Novel pharmaceutical compositions of clopidogrel mesylate
IS2385B (en) * 2006-02-10 2008-07-15 Actavis Group Hf. Clopidogrel bisulfate pharmaceutical compositions
CZ2006160A3 (en) * 2006-03-09 2007-09-05 Zentiva, A. S Hydrogen bromide clopidogrel pharmaceutical composition hydro
US20100145053A1 (en) * 2006-04-05 2010-06-10 Cadila Healthcare Limited Modified release clopidogrel formulation
EP1847259B8 (en) * 2006-04-13 2010-04-14 RIEMSER Specialty Production GmbH Compositions comprising thieno[2,3-c]pyridine derivatives as active agents with poloxamers as lubricants
PT1847258E (en) 2006-04-13 2010-06-22 Riemser Specialty Production G Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives
WO2007128476A1 (en) * 2006-05-04 2007-11-15 Sandoz Ag Pharmaceutical compositions containing clopidogrel hydrochloride
KR20080055356A (en) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 Inclusion complex of clopidogrel and beta-cyclodextrin
KR20080055355A (en) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 Inclusion complex of clopidogrel and beta-cyclodextrin
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
EP2148655B1 (en) * 2007-04-20 2013-02-27 Wockhardt Limited Pharmaceutical compositions of clopidogrel
ATE530172T1 (en) * 2008-02-26 2011-11-15 Lesvi Laboratorios Sl PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
PL2112155T3 (en) 2008-04-25 2011-03-31 Sandoz Ag Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
EP2398468B1 (en) 2009-02-17 2016-11-30 KRKA, D.D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
JP2013032289A (en) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd Wax stable formulation
ES2363964B1 (en) 2009-11-20 2012-08-22 Gp Pharm, S.A. CAPSULES OF PHARMACEUTICAL ACTIVE PRINCIPLES AND ESTERS OF POLYINSATURATED FATTY ACIDS.
CN101766573B (en) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 Preparation process of clopidogrel bisulfate solid preparation
CN101851247B (en) * 2010-06-04 2013-05-29 浙江华海药业股份有限公司 Composition containing clopidogrel bisulfate crystal particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
EP1606231A1 (en) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Process for preparation of clopidogrel, its salts and pharmaceutical compositions

Also Published As

Publication number Publication date
EP1682096A1 (en) 2006-07-26
AU2004290511A1 (en) 2005-06-02
JP2007527414A (en) 2007-09-27
WO2005048992A1 (en) 2005-06-02
CN101848705A (en) 2010-09-29
BRPI0416109A (en) 2007-01-02
CA2540965A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
GB0301259D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
GB0306715D0 (en) Organic compounds
GB0307553D0 (en) Organic compounds
SI1651034T1 (en) Organic compounds
GB0302876D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0301471D0 (en) Organic compounds
GB0303506D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0307440D0 (en) Organic compounds
GB0307277D0 (en) Organic compounds
GB0302433D0 (en) Organic compounds
GB0303323D0 (en) Organic compounds
GB0301262D0 (en) Organic compounds
GB0301470D0 (en) Organic compounds
GB0300591D0 (en) Organic compounds
GB0301561D0 (en) Organic compounds
GB0301692D0 (en) Organic compounds
GB0300590D0 (en) Organic compounds
GB0306323D0 (en) Organic compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: SANDOZ AG

Free format text: FORMER APPLICANT(S): SANDOZ GMBH

AT Applications terminated before publication under section 16(1)